PRESS STATEMENTS07.16.2021 Pfizer Issues A Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (varenicline) Tablets Due to N-Nitroso Varenicline Content07.16.2021 U.S. FDA Grants Priority Review for the Biologics License Application for Pfizer-BioNTech COVID-19 Vaccine07.08.2021 Pfizer and BioNTech Provide Update on Booster Program in Light of the Delta-Variant07.08.2021 Newly Published Expert Opinion Article Details Evidence for Classifying Aging Immune System as a High-Risk Condition for Pneumococcal Vaccine Policy06.11.2021 XELJANZ® Safety Review Recommendation Issued in the European Union05.28.2021 Pfizer Colleagues To Mentor Veterans In Transition To Civilian Life05.11.2021 Pfizer’s Novel Prediction Model, Derived from Machine Learning, Shows Robust Performance for Identifying Heart Failure Patients At-Risk for Wild-Type Transthyretin Amyloid Cardiomyopathy, a Rare and Life-Threatening Condition Associated with Progressive H05.04.2021 Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling05.04.2021 Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate04.22.2021 Pfizer Announces 2021 Shareholder Meeting Results04.09.2021 Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents03.03.2021 Pfizer-BioNTech’s COVID-19 Vaccine Arrives in Rwanda02.25.2021 Pfizer Statement on Results of Second Annual Pay Equity Study Among Colleagues Worldwide02.19.2021 President Biden Visits Pfizer’s Kalamazoo Manufacturing Facility02.17.2021 In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer- BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations02.08.2021 Pfizer and BioNTech Publish Data from in Vitro Studies in "Nature Medicine" Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants02.01.2021 Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature01.29.2021 Pfizer and BioNTech Publish Data on COVID-19 Vaccine-Induced Antibodies’ Ability to Neutralize SARS-CoV-2 U.K. Strain Pseudovirus in Cell Culture in Science01.27.2021 In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants01.26.2021 Statement on ATMI RankingPagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkDiverse Perspectives Podcastmenopause: unmutedHemcastContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesOur PeopleThanking John Young for His Years of Service to Pfizer – and to…Our PurposeIncreased Access to Biosimilars Could Save the U.S. Healthcare…Your HealthTranslating Technical Language into Plain Language for Clinical…Our PurposeHow 10 Biopharma Companies are Working Together to Bring…Our PeopleView for the FutureYour HealthA "Ticklist" For Staying Safe While Spending Time…Your HealthHealth Screenings Every African American Man Should KnowOur SciencemRNA – Technology at the Forefront During Global PandemicYour HealthEmpowering Patients by Closing the Health Literacy GapOur PurposeMaking a Global Impact in Breast Cancer CareYour HealthAre You Familiar with AFib Symptoms and the Increased Risk of…Your HealthIn Their Words: Five People with Ulcerative Colitis Speak Up…Our PurposeDoing Better: Increasing Diversity in Clinical TrialsOur PurposePartnering to RETHINK Vaccine Confidence and RE:SET Mental…Our PurposeImproving Metastatic Breast Cancer Care for Underserved…Our ScienceAn Open Letter from Pfizer Chairman and CEO to ColleaguesOur PurposeReimagining Primary Healthcare in Bogor, IndonesiaOur PurposeSupporting India in Its Time of NeedOur PeopleMeet Dacia Young, a Senior Scientist within the Vaccine Research…Our PurposeWisconsin is Ready for CuresOur PurposeMichigan is Ready for CuresShowHide
